Physical activity and exercise in the context of SARS-Cov-2: A perspective from geroscience field

Abstract

The recent pandemics of the SARS-Cov-2 has pushed physical activity (PA) and exercise at the forefront of the discussion, since PA is associated with a reduced risk of developing all the chronic diseases strongly associated with severe cases of SARS-Cov-2 and exercise is considered a complimentary therapeutics for the treatment of these age-related conditions. The mechanisms through which PA and exercise could contribute to reduce the severity of the SARS-Cov-2 infection would be multiple, including their capacity to boost the immune system, but also their global effect on slowing down the progression of the aging process. The present perspective presents a discussion on how PA and exercise might hypothetically be linked with SARS-Cov-2 infection, current scientific gaps and shortcomings as well as recommendations for advancing research in this area, placing the debate in the context of aging and gerosciences.

COVID-19 Infection Alters the Microbiome: Elite Athletes and Sedentary Patients Have Similar Bacterial Flora

“…It is known that the microbiome plays an important role in the immune system, and it is suggested that regular exercise has the capacity to boost the immune system [10,15,34]. On the other hand, our data revealed no significant difference in the microbiome of competing athletes and sedentary subjects during and after COVID-19 infection.…”

Current Status of Endolysin-Based Treatments against Gram-Negative Bacteria

“…The majority of endolysin-based products have topical uses, which are ideal for skin and wound infections, but not suitable for many other parts of the body. Due to the protein character of endolysins, the oral administration of endolysins is difficult given that drugs must transit the entirety of the gastrointestinal tract [87]. Considering other administration routes, endolysins can trigger the immune system [88].…”